Trials / Completed
CompletedNCT00674570
Veteran Stress and Learning Study
Effects of Hydrocortisone and D-Cycloserine on Fear Extinction in Veterans With Posttraumatic Stress Disorder
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 111 (actual)
- Sponsor
- VA Office of Research and Development · Federal
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This is a research study examining the use of two medications, Hydrocortisone and D-Cycloserine, compared to an inactive substance (placebo), on their ability to reduce fear responses and memory of fear in Veterans with symptoms of Posttraumatic Stress Disorder (PTSD). These responses will be tested using a fear learning and memory task administered by computer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hydrocortisone | 25 mg/oral one hour prior to extinction task |
| DRUG | D-Cycloserine | 50 mg/oral one hour prior to extinction task |
| DRUG | Placebo | One hour prior to extinction task |
Timeline
- Start date
- 2009-01-13
- Primary completion
- 2015-06-22
- Completion
- 2015-06-22
- First posted
- 2008-05-08
- Last updated
- 2019-05-30
- Results posted
- 2019-05-30
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT00674570. Inclusion in this directory is not an endorsement.